BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35571642)

  • 1. Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis.
    Cui S; Lou S; Feng J; Tang X; Xiao X; Huang R; Guo W; Zhou Y; Huang F
    Transl Cancer Res; 2022 Apr; 11(4):710-724. PubMed ID: 35571642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of hub genes associated with prognosis in non-small cell lung cancer by integrated bioinformatics analysis.
    Zeng Y; Li N; Chen R; Liu W; Chen T; Zhu J; Zeng M; Cheng J; Huang J
    Transl Cancer Res; 2020 Nov; 9(11):7149-7164. PubMed ID: 35117319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation.
    Yin Y; Li D; He M; Wang J
    Transl Cancer Res; 2022 Aug; 11(8):2622-2635. PubMed ID: 36093542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of significant genes in non-small cell lung cancer by bioinformatics analyses.
    Ye X; Gao Q; Wu J; Zhou L; Tao M
    Transl Cancer Res; 2020 Jul; 9(7):4330-4340. PubMed ID: 35117799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.
    Shi Y; Li Y; Yan C; Su H; Ying K
    Oncol Lett; 2019 Dec; 18(6):5859-5870. PubMed ID: 31788059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico analysis revealed the potential circRNA-miRNA-mRNA regulative network of non-small cell lung cancer (NSCLC).
    Balasundaram A; C GPD
    Comput Biol Med; 2023 Jan; 152():106315. PubMed ID: 36495751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of key genes associated with non-small-cell lung cancer.
    Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
    J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key genes associated with progression and prognosis for lung squamous cell carcinoma.
    Ma X; Ren H; Peng R; Li Y; Ming L
    PeerJ; 2020; 8():e9086. PubMed ID: 32411535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of potential biomarkers and their predictive value in early stage non-small cell lung cancer: a bioinformatics analysis.
    Tu H; Wu M; Huang W; Wang L
    Transl Lung Cancer Res; 2019 Dec; 8(6):797-807. PubMed ID: 32010558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key candidate tumor biomarkers in non-small-cell lung cancer by
    Chen W; Zhu S; Zhang Y; Xiao J; Tian D
    Oncol Lett; 2020 Jan; 19(1):1008-1016. PubMed ID: 31897214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated bioinformatics analysis of microarray data from the GEO database to identify the candidate genes linked to poor prognosis in lung adenocarcinoma.
    Liu X; Li L; Xie X; Zhuang D; Hu C
    Technol Health Care; 2023; 31(2):579-592. PubMed ID: 36336945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics.
    Cai K; Xie Z; Liu Y; Wu J; Song H; Liu W; Wang X; Xiong Y; Gan S; Sun Y
    Biomed Res Int; 2023; 2023():2152432. PubMed ID: 36714024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis.
    Ni M; Liu X; Wu J; Zhang D; Tian J; Wang T; Liu S; Meng Z; Wang K; Duan X; Zhou W; Zhang X
    Front Genet; 2018; 9():469. PubMed ID: 30369945
    [No Abstract]   [Full Text] [Related]  

  • 16. Hub genes and key pathways of non-small lung cancer identified using bioinformatics.
    Tang Q; Zhang H; Kong M; Mao X; Cao X
    Oncol Lett; 2018 Aug; 16(2):2344-2354. PubMed ID: 30008938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis.
    Cao L; Chen Y; Zhang M; Xu DQ; Liu Y; Liu T; Liu SX; Wang P
    PeerJ; 2018; 6():e5180. PubMed ID: 30002985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.
    Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z
    Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.